Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet activating factor antagonists interact with GABAA receptors.

L G Miller1, N G Bazan, R B Roy

  • 1Department of Medicine, LSU Medical Center, New Orleans 70112.

Research Communications in Chemical Pathology and Pharmacology
|November 1, 1991
PubMed
Summary

Platelet-activating factor (PAF) antagonists, BN 52021 and BN 52115, enhance GABAA receptor function by increasing chloride uptake. This augmentation of GABAA receptor activity occurs without altering binding affinity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk factors for transmission of carbapenem-resistant Enterobacterales to healthcare personnel gloves and gowns in the USA.

The Journal of hospital infection·2020
Same author

Sociodemographic factors associated with patients hospitalised for coccidioidomycosis in California and Arizona, State Inpatient Database 2005-2011.

Epidemiology and infection·2020
Same author

Bayesian evidence and epidemiological implications of environmental contamination from acute respiratory infection in long-term care facilities.

Epidemiology and infection·2018
Same author

Discontinuation of contact precautions with the introduction of universal daily chlorhexidine bathing.

Epidemiology and infection·2017
Same author

Incidence and factors associated with emergency department visits for recurrent skin and soft tissue infections in patients in California, 2005-2011.

Epidemiology and infection·2016
Same author

Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2016

Area of Science:

  • Neuroscience
  • Pharmacology
  • Neurochemistry

Background:

  • Platelet-activating factor (PAF) is a ubiquitous signaling molecule in mammals with diverse roles, including potential functions within the central nervous system.
  • Triazolobenzodiazepine compounds exhibit dual activity, interacting with both the GABAA receptor and acting as PAF antagonists.

Purpose of the Study:

  • To investigate the potential involvement of PAF antagonist activity in the central nervous system actions of triazolobenzodiazepines.
  • To examine the effects of non-benzodiazepine PAF antagonists on GABAA receptor binding and function.

Main Methods:

  • Assessed the impact of BN 52021 (a gingkolide terpene) and BN 52115 (a dioxolane-based compound) on benzodiazepine and chloride channel binding in cortical membrane preparations.
  • Measured chloride uptake into cortical synaptoneurosomes to evaluate GABAA receptor function.

Related Experiment Videos

  • Investigated the effect of flumazenil on BN 52021-induced changes in chloride uptake.

    • Main Results:

    • Neither BN 52021 nor BN 52115 affected benzodiazepine or chloride channel binding at the GABAA receptor.
    • BN 52021 significantly enhanced chloride uptake into cortical synaptoneurosomes at a concentration of 1 microM, while BN 52115 did not.
    • The enhancing effect of BN 52021 on chloride uptake was reversed by the co-administration of 1 microM flumazenil.

    Conclusions:

    • PAF antagonists can modulate GABAA receptor function, specifically enhancing chloride ion transport.
    • The observed augmentation of GABAA receptor function by PAF antagonists occurs independently of changes in receptor binding affinity.
    • These findings suggest a novel mechanism by which PAF antagonists may influence neuronal activity via GABAA receptor modulation.